期刊文献+

早期鼻腔NK/T细胞淋巴瘤三组放射治疗剂量的效果比较 被引量:2

Comparison of effect of three radiation doses for early stage nasal NK /T cell lymphoma
下载PDF
导出
摘要 目的探讨放疗剂量对早期鼻腔NK/T细胞淋巴瘤预后的影响。方法将64例早期鼻腔NK/T细胞淋巴瘤患者,根据放疗剂量大小分为〈50Gy组(n=20),51~60Gy组(n=24)和〉60Gy组(n=20),观察比较各组局部控制率和5年生存率。结果经随访〈50Gy组局部控制率68.5%,5年生存率42.1%。51~60Gy组局部控制率达到82.5%,生存率达60.9%。两组对比在局部控制率和5年生存率有统计学意义(P〈0.05),但51—60Gy组和〉60Gy组对比无统计学意义。结论以51—60Gy剂量的放疗能保证良好的局部控制率,提高患者总生存率,建议临床在选择放疗剂量时以51—60Gy为宜。 Objective To study the effects of different radiotherapy doses on the early stage nasal NK/T cell lymphoma. Methods 64 patients with early stage nasal NK/T cell lymphoma undergoing radiotherapy were divided into 〈 50 Gy group ( n = 20), 51-60 Gy group(n =24) and 〉60 Gy group(n =20) , all groups were observed and their local control rate and survival rate of 5 years were compared. Results The total local control rates in the three groups were 68.5%, 82.5% and 72.2% respectively. There was significant difference in the local control rate and survival rate of 5 years between 〈 50 Gy group and the other two groups 51-60 Gy and 〉 60 Gy group) (P 〈 0.05 ), but the differences between the two groups were not statistically significant. Conclusions 51-60 Gy doses of radiation can guarantee good local control rate, improve overall survival rate. The choice of radiation doses to 50 Gym patients with early stage nasal NK/T cell lymphoma is appropriate, with clinical recommendations.
出处 《武警医学》 CAS 2014年第6期560-561,565,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 淋巴瘤 鼻腔 NKT细胞淋巴瘤 放疗剂量 预后 lymphoma nasal cavity NK/T cell lymphoma radiotherapy prognosis
  • 相关文献

参考文献7

二级参考文献50

  • 1潘战和,黄慧强,林旭滨,夏云飞,夏忠军,彭玉龙,蔡清清,林桐榆,姜文奇,管忠震.鼻型NK/T细胞非霍奇金淋巴瘤预后因素探讨(附93例长期随访结果分析)[J].癌症,2005,24(12):1493-1497. 被引量:24
  • 2姚波,李晔雄,房辉,余子豪,金晶,刘新帆.116例早期鼻腔NK/T细胞淋巴瘤患者的治疗结果和预后因素分析[J].中华血液学杂志,2006,27(4):222-225. 被引量:10
  • 3肖健,王树森,黄岩,陈丽昆,管忠震,黄慧强,夏忠军,徐瑞华,林桐榆.62例鼻型NK/T细胞淋巴瘤的预后因素分析[J].癌症,2006,25(9):1173-1177. 被引量:5
  • 4顾大中 王奇璐 等.恶性淋巴瘤的综合治疗[J].中华放射肿瘤学杂志,1996,5(1):25-28.
  • 5Chan JKC,Quintanilla-Martinez L,Ferry JA,et al.Extranodal NK/T-cell lymphoma,nasal type//Jaffe ES,Hams NL,Stein H,et al,eds.World Health Organization classification of tumors:pathology and genetics of tumors of haematopoietic and lymphoid tissues.Lyon:IARC Press.2008:285-288.
  • 6Li YX,Fang H,Liu QF,et al.Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring.Blood,2008,112:3057-3064.
  • 7Li YX,Liu QF,Fang H,et al.Variable clinical presentations of nasal and Waldeyer Ring natural killer/T-cell lymphoma.Clin Cancer Res,2009,15:2905-2912.
  • 8Kim TM,Lee SY,Jeon YK,et al.Clinical heterogeneity of extranodal NK/T-cell lymphoma,nasal type:a national survey of the Korean Cancer Study Croup.Ann Oncol,2008,19:1477-1484.
  • 9Au WY,Weisenburger DD,Intragumtornchai T,et al.Clinical differences between nasal and extranasal NK/T-cell lymphoma:a study of 136 cases from the International Peripheral T-cell Lymphoma Project.Blood,2009,113:3931 -3937.
  • 10Li YX,Coucke PA,Li JY,et al.Primary non-Hodgkin's lymphoma of the nasal cavity:prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.Cancer,1998,83:449-456.

共引文献32

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部